Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MACROGENICS INC Director's Dealing 2020

Sep 21, 2020

34129_dirs_2020-09-21_90c927ad-861a-443a-9b1a-d939b61dba91.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2020-09-17

Reporting Person: Bonvini Ezio (Sr VP, Research & CSO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-09-17 Common Stock S 44512 $29.88 Disposed 102146 Direct
2020-09-18 Common Stock S 18339 $32 Disposed 83807 Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020.

F2: This transaction was executed in multiple trades at prices ranging from $28.59 to $31.35. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F3: This transaction was executed in multiple trades at prices ranging from $32.00 to $32.01. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.